Current molecular pharmacology

Keyphrases

Publications

2024

Kun-Chen Lin, Kuan-Hung Chen, Pei-Lin Shao, Han-Tan Chai, Pei-Hsun Sung, John Y Chiang, Sheung-Fat Ko, Hon-Kan Yip
Combined Phloretin and Human Platelet-rich Plasma Effectively Preserved Integrities of Brain Structure and Neurological Function in Rat after Traumatic Brain Damage. Current molecular pharmacology (2024)
Rozita Khodashahi, Mahmoud Tavakkoli, Gorgon A Ferns, Leyla Feyzmohammadi, Amir Hossein Mirzaei, Mohsen Aliakbarian, Mohammad-Hassan Arjmand
Adipose Tissue Dysfunction Following Trauma and Hypoxia Increases the Risk of Post-Surgical Adhesion: Potential for Therapeutic Interventions. Current molecular pharmacology (2024)
Sharmeen Fayyaz, Atia Tul-Wahab, Bushra Taj, M Iqbal Choudhary
Positive Regulation of Osteoblast Proliferation and Differentiation in MC3T3- E1 Cells by 7,3',4'-Trimethoxyflavone. Current molecular pharmacology (2024)
Shirin Moazen, Mohammad-Hassan Arjmand
The Role of Local Angiotensin II/Angiotensin Type 1 Receptor in Endometriosis: A Potential Target for New Treatment Approaches. Current molecular pharmacology (2024)
Yan Huang, Weichao Sun, Danli Zhu, Li Liu, Jian-Guo Feng, Qian Yi
RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K/AKT Signaling Pathway. Current molecular pharmacology (2024)
Ting Gong, Gui Cao, Danyang Sun, Tongtong Ge, Ping Li
The Roles of mTOR Signaling in Nasopharyngeal Carcinoma: From Pathogenesis to Therapy. Current molecular pharmacology (2024)
Zizhe Ma, Zhenzhou Bai, Bohan Li, Yue Zhang, Wei Liu
Artemisinin Alleviates Myocardial Remodeling through TGF-β1/Smad2/3 Pathway and NLRP3 Inflammasome. Current molecular pharmacology (2024)
Rui-Feng Liang, Wenjing Ge, Xianmei Song, Huisen Wang, Weifeng Cui, Xuexia Zhang, Zheng Wei, Gengsheng Li
Paeoniflorin Alleviates Anxiety and Visceral Hypersensitivity via HPA Axis and BDNF/TrkB/PLCγ1 Pathway in Maternal Separation-induced IBS-like Rats. Current molecular pharmacology (2024)
Mei Li, Jiaoxiu Fan, Min Hu, Junyu Xu, Ziyue He, Jun Zeng
Quercetin Enhances 5-fluorouracil Sensitivity by Regulating the Autophagic Flux and Inducing Drp-1 Mediated Mitochondrial Fragmentation in Colorectal Cancer Cells. Current molecular pharmacology (2024)
Citlali Margarita Blancas-Napoles, Sandra Edith Cabrera-Becerra, Vivany Maydel Sierra-Sánchez, Sergio Adrian Ocampo-Ortega, Vanessa Giselle Garcia-Rubio, Rodrigo Romero-Nava, Fengyang Huang, Enrique Hong, Asdrúbal Aguilera-Méndez, Santiago Villafaña
siRNA Targeting ECE-1 Partially Reverses Pulmonary Arterial Hypertensionassociated Damage in a Monocrotaline Model. Current molecular pharmacology (2024)
Natalia Nazarenko, Jiyoung Seo, Sanjana Nagraj, Leonidas Palaiodimos, Damianos G Kokkinidis
RNA Interference-based Therapies for the Reduction of Cardiovascular Risk. Current molecular pharmacology (2024)
Bruno Sensi, Roberta Angelico, Luca Toti, Luigi Conte, Alessandro Coppola, Giuseppe Tisone, Tommaso Maria Manzia
Mechanism, Potential, and Concerns of Immunotherapy for Hepatocellular Carcinoma and Liver Transplantation. Current molecular pharmacology (2024)
Luo Qiong, Xiao Shuyao, Xu Shan, Fu Qian, Tan Jiaying, Xiao Yao, Ling Hui
Recent Advances in the Glycolytic Processes Linked to Tumor Metastasis. Current molecular pharmacology (2024)
Tahereh Farkhondeh, Babak Roshanravan, Fariborz Samini, Saeed Samarghandian
Effect of Chrysin and Chrysin Nanocrystals on Chlorpyrifos-Induced Dysfunction of the Hypothalamic-Pituitary-Testicular Axis in Rats. Current molecular pharmacology (2024)
Amir Masoud Jafari-Nozad, Negin Rostami, Melika Esmaeili, Haniye Vahdati, Serajoddin Hosseini, Tahereh Farkhondeh, Saeed Samarghandian
A Review of the Dual Role of MicroRNA-21 in Cardiovascular Diseases: Risk Factor or a Potential Therapeutic Target. Current molecular pharmacology (2024)
Alice Bombino, Marcello Magnani, Alfredo Conti
A Promising Breakthrough: The Potential of VORASIDENIB in the Treatment of Low-grade Glioma. Current molecular pharmacology (2024)
Fumiya Shibagaki, Naoko Kojima, Akane Furukawa, Noritaka Nakamichi
Depression-like Behavior Induced by Repeated Administration of Dexamethasone to Lipopolysaccharide-inflamed Mice. Current molecular pharmacology (2024)
Alireza Moslem, Rozita Khodashahi, Gordon A Ferns, Mohsen Aliakbarian, Mohammad-Hassan Arjmand
The Therapeutic Potential of Targeting the Connexin43 as a New Approach to Reducing Post-Surgical Adhesion. Current molecular pharmacology (2024)
Birnur Aydin, Cansu Koc, Mehmet Cansev, Tülin Alkan
Short-term Uridine Treatment Alleviates Endoplasmic Reticulum Stress via Regulating Inflammation and Oxidative Stress in Lithium-Pilocarpine Model of Status Epilepticus. Current molecular pharmacology (2024)
Yunzhi Zhu, Yi Hu, Chengsheng Yang, Shipu Huang, Jianping Wen, Weiguo Huang, Shengjun Xiao
Progress of Angiogenesis Signal Pathway and Antiangiogenic Drugs in Nasopharyngeal Carcinoma. Current molecular pharmacology (2024)
Li Yuan, Liang Zeng, Feng Ye, Kai Chen, Zhengrong Chen, Liping Li
IMPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway. Current molecular pharmacology (2024)
Amin Reza Nikpoor, Mahmoud Mahmoudi, Abbas Shapouri-Moghaddam, Zahra Rezaieyazdi, Samaneh Mollazadeh, Nafiseh Tabasi, Atena Mansouri, Reyhane Modarres Moghadam, Amir Abbas Momtazi, Soran K Najmaldin, Ramiar Kamal Kheder, Seyed-Alireza Esmaeili
Curcumin and Berberine Arrest Maturation and Activation of Dendritic Cells Derived from Lupus Erythematosus Patients. Current molecular pharmacology (2024)
Zahra Salari, Maryam Alavi, Hojjat Rezaii-Zadeh, Abdelhakim Bouyahya, Ammar Alfergah, Sahar Afsari Sardari, Ehsan Amiri-Ardekani
Alnustone: A review of its sources, pharmacology, and pharmacokinetics ‏‏. Current molecular pharmacology (2024)
Huiling Xu, Jinghong Huang, Lixia Yao, Wenyi Gu, Aynisahan Ruzi, Yufei Ding, Ying Li, Weihua Liang, Jinfang Jiang, Zemin Pan, Dongdong Cao, Naiming Zhou, Dongmei Li, Jinli Zhang
An Essential Role of c-Fos in Notch1-mediated Promotion of Proliferation of KSHV-Infected SH-SY5Y Cells. Current molecular pharmacology (2024)
Jie Shen, Wenqin Xiao, Guanzhao Zong, Pengli Song, Chuanyang Wang, Jingpiao Bao, Qi Peng, Zhu Mei, Jingjing Wang, Ruiyan Wang, Jing Jiang, Rong Wan, Jianbo Ni, Xingpeng Wang, Guoyong Hu
Calpain Inhibitor Calpeptin Improves Pancreatic Fibrosis in Mice with Chronic Pancreatitis by Inhibiting the Activation of Pancreatic Stellate Cells. Current molecular pharmacology (2024)
Mohammad Hossein Pourhanifeh, Hossein Farrokhi-Kebria, Parsa Mostanadi, Tahereh Farkhondeh, Saeed Samarghandian
Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms. Current molecular pharmacology (2024)

volume 17, number 1, 2024

Chang Liu, Xiujuan Wen
Mass Spectrometry in Covalent Drug Discovery. Current molecular pharmacology 17 (1) (2024)

volume 17, 2024

Chun-Li Yin, Yu-Jie Ma
The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance. Current molecular pharmacology 17 (2024)
Dipanjan Karati, Dileep Kumar
Molecular Insight into the Apoptotic Mechanism of Cancer Cells: An Explicative Review. Current molecular pharmacology 17 (2024)
Paulo A F Pacheco, Robson Xavier Faria
Are Purinergic Receptors Overlooked Targets in Hyperinflammatory Responses? Current molecular pharmacology 17 (2024)
Wu Wang, Xiujin Xu, Mei Yang, Mengya Jiang, Dandan Wang, Caihong Tang, Wei Wei, Jingyu Chen
Ginsenoside Compound K Reduces Psoriasis-related Inflammation by Activation of the Glucocorticoid Receptor in Keratinocytes. Current molecular pharmacology 17 (2024)
Ali Mohammad Pourbagher-Shahri, Tahereh Farkhondeh, Amir Masoud Jafari-Nozad, Majid Darroudi, Kobra Naseri, Masoumeh Amirian, Saeed Samarghandian
Nrf2 Mediates Effect of Resveratrol in Ischemia-reperfusion Injury. Current molecular pharmacology 17 (2024)
Chun-Li Yin, Yu-Jie Ma
The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance. Current molecular pharmacology 17 (2024)
Asmat Ullah, Anum Razzaq, Mohammad Y Alfaifi, Serag Eldin I Elbehairi, Farid Menaa, Najeeb Ullah, Somia Shehzadi, Touseef Nawaz, Haroon Iqbal
Sanguinarine Attenuates Lung Cancer Progression via Oxidative Stress-induced Cell Apoptosis. Current molecular pharmacology 17 (2024)
Zizhe Ma, Zhenzhou Bai, Bohan Li, Yue Zhang, Wei Liu
Extracts from Artemisia annua Alleviates Myocardial Remodeling through TGF-β1/Smad2/3 Pathway and NLRP3 Inflammasome Current molecular pharmacology 17 (2024)
Zizhe Ma, Zhenzhou Bai, Bohan Li, Yue Zhang, Wei Liu
Extracts from Artemisia annua Alleviates Myocardial Remodeling through TGF-β1/Smad2/3 Pathway and NLRP3 Inflammasome Current molecular pharmacology 17 (2024)
Jasper Okoro Godwin Elechi, Diana Marisol Abrego Guandique, Roberto Cannataro
Creatine in Cognitive Performance: A Commentary. Current molecular pharmacology 17 (2024)
Dipanjan Karati, Dileep Kumar
Molecular Insight into the Apoptotic Mechanism of Cancer Cells: An Explicative Review. Current molecular pharmacology 17 (2024)
Jianqiu Han, Chen Zhao, Qing Shen, Yalei Qi, Yanjia Zhang, Faisal Raza, Yongmei Li, Hajra Zafar, Tengfei Liu, Juan Tan, Honghui Han, Xueyun Ma
Impact of Nicosulfuron on Sperm Quality: Insights into Testicular Cell Apoptosis and NF-κB Signaling Pathway in Mice Testes. Current molecular pharmacology 17 (2024)
Mohammad Hossein Pourhanifeh, Hossein Farrokhi-Kebria, Parsa Mostanadi, Tahereh Farkhondeh, Saeed Samarghandian
Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms. Current molecular pharmacology 17 (2024)
Mohammad Hossein Pourhanifeh, Hossein Farrokhi-Kebria, Parsa Mostanadi, Tahereh Farkhondeh, Saeed Samarghandian
Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms. Current molecular pharmacology 17 (2024)
Liqi Li, Yunyun Li, Xiaoshu Zhou
Advancements in the Research of GEF-H1: Biological Functions and Tumor Associations. Current molecular pharmacology 17 (2024)

2023

Sheetal Kiran, Abhilipsa Patra, Poonam Verma, Suvendu Purkait, Gaurav Chhabra, Praveen Kumar Guttula, Amit Ghosh
Restoration of Altered Oncogenic and Tumor Suppressor microRNA Expression in Breast Cancer and Colorectal Cancer Cell using Epicatechin. Current molecular pharmacology (2023)
Juan Hao, Jian Wu, Quan-Jun Yang, Kan Lu, Yi Xu, Yiyue Chen, Jibo Liu, Xiaohong Shao, Chunling Zhu, Yaqin Ding, Xin Xie
Gentiopicroside Ameliorated Ductular Reaction and Inflammatory Response in DDC-induced Murine Cholangiopathies Model. Current molecular pharmacology (2023)
Ming Tatt Lee, Yu-Cheng Ho
Ketamine Metabolites-Waiting In The Wings As Therapeutic Candidate for Depression? Current molecular pharmacology (2023)

volume 17, number 1, 2023

Lirui Liang, Yang Li, Yang Jiao, Chunjing Zhang, Mingguang Shao, Hanyu Jiang, Zunge Wu, Haoqi Chen, Jiaming Guo, Huijie Jia, Tiesuo Zhao
Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma. Current molecular pharmacology 17 (1) (2023)
Jian-Guo Feng, Menghong Long, Xin Zhao, Pijun Yan, Yunxiao Lin, Maohua Wang, Wenhua Huang
RBM3 Accelerates Wound Healing of Skin in Diabetes through ERK1/2 Signaling. Current molecular pharmacology 17 (1) (2023)
Shan-Fu Yu, Tien-Tsai Cheng, Gong-Kai Huang, Chung-Yuan Hsu, Ying-Hsien Kao, Yueh-Hua Chung
Targeting FGFR3 is a Useful Therapeutic Strategy for Rheumatoid Arthritis Treatment. Current molecular pharmacology 17 (1) (2023)

volume 16, number 3, 2023

Baljinder Singh
Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review. Current molecular pharmacology 16 (3) (2023)
Baljinder Singh
Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review. Current molecular pharmacology 16 (3) (2023)